DRUG THERAPY FOR PROTEIN COMPOSITION CHANGES OF BLOOD IN HYPERTENSION AND IN CASES OF COMORBIDITY

DRUG THERAPY FOR PROTEIN COMPOSITION CHANGES OF BLOOD IN HYPERTENSION AND IN CASES OF COMORBIDITY

Background. The binding function of serum albumin (BFSA) and its changes in various diseases in recent years are of interest to researchers. Hypertension (HT) in combination with comorbidities, including non-alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (DM) can contribute to BFSA....

Full description

Bibliographic Details
Main Authors:	Yu. R. Dzordzo, S. M. Andreychyn
Format:	Article
Language:	English
Published:	Ukrmedknyha 2022-04-01
Series:	International Journal of Medicine and Medical Research
Subjects:	hypertension non-alcoholic steatohepatitis type 2 diabetes mellitus binding function of serum albumin antral®
Online Access:	https://ojs.tdmu.edu.ua/index.php/ijmr/article/view/12682

Similar Items

Dynamics of changes in serum albumin binding function and endogenous intoxication in patients with hypertension and comorbid states when using a hepatoprotector
by: Yu.R. Dziordzio, et al.
Published: (2022-02-01)

Search for a way to improve the serum albumin binding function and the functional state of the liver when hypertension combined with non-alcoholic fatty liver disease
by: Yurii Dzordzo, et al.
Published: (2022-01-01)

EFFICIENCY OF COMPLEX PATHOGENIC APPROACH FOR TREATMENT OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS COMBINED WITH TYPE 2 DIABETES MELLITUS
by: S. Pavlovskyi
Published: (2018-09-01)

OXIDATIVE STRESS INTENSITY AND STATE OF SEPARATE ANTIOXIDANT PROTECTION FACTORS IN ANTRALE TREATMENT IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS, OBESITY, AND CHRONIC OBSTRUCTIVE LUNG DISEASE
by: O. S. Khukhlina, et al.
Published: (2020-06-01)

Association Between Serum Albumin Levels and Diabetic Peripheral Neuropathy Among Patients with Type 2 Diabetes: Effect Modification of Body Mass Index
by: Hu Y, et al.
Published: (2022-02-01)

Catestatin in diagnosing cardiovascular and metabolic disorders in patients with comorbid hypertension
by: I.P. Dunaieva, et al.
Published: (2023-06-01)

FREQUENCY OF ANXIETY DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION AND COMORBID DISEASES
by: Elena A. Pronina, et al.
Published: (2023-12-01)

Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities
by: Jorge Simón, et al.
Published: (2021-01-01)

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
by: Julia A. Golubeva, et al.
Published: (2023-09-01)

Correlation of serum albumin with ischemia modified albumin in acute stroke patients with or without diabetes mellitus
by: Jayaraj G Gudi, et al.
Published: (2017-01-01)

The glycemic profile in patients with non-alcoholic steatohepatitis and type 2 diabetes depending on diabetic kidney disease
by: Z.Ya. Kotsiubiichuk, et al.
Published: (2023-09-01)

Assessment of Vitamin D Levels in Relation to Statin Therapy in Elderly Hypertensive Patients with Comorbidities
by: Nyulas Kinga-Ilona, et al.
Published: (2022-12-01)

Inverse association of serum albumin levels with diabetic retinopathy in type 2 diabetic patients: a cross-sectional study
by: Xianhua Li, et al.
Published: (2024-02-01)

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
by: Torre E, et al.
Published: (2022-09-01)

Quantification and Improvement of the Dynamics of Human Serum Albumin and Glycated Human Serum Albumin with Astaxanthin/Astaxanthin-Metal Ion Complexes: Physico-Chemical and Computational Approaches
by: Syahputra Wibowo, et al.
Published: (2022-04-01)

QSAR Models for the Prediction of Plasma Protein Binding
by: Zeshan Amin, et al.
Published: (2013-02-01)

Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status
by: A. A. Shipovskaya, et al.
Published: (2021-05-01)

Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches
by: Tanveer A. Wani, et al.
Published: (2022-02-01)

Binding Constants of Clinical Drugs and Other Organic Ligands with Human and Mammalian Serum Albumins
by: Igor Sedov, et al.
Published: (2021-09-01)

Psychosocial and behavioral correlates of self-efficacy in treatment adherence in older patients with comorbid hypertension and type 2 diabetes
by: Antonia Pierobon, et al.
Published: (2023-03-01)

THE EFFECT OF BICYCLOL ON THE STATE OF THE CONNECTIVE TISSUE COMPONENTS OF THE LIVER EXTRACELLULAR MATRIX IN THE COMPLEX THERAPY OF NON-ALCOHOLIC STEATOHEPATITIS WITH LIVER FIBROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: Zorіana Ya. Kotsіubiіchuk, et al.
Published: (2021-12-01)

Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis
by: Xue H, et al.
Published: (2023-05-01)

Association of Alcohol Intake With Hypertension in Type 2 Diabetes Mellitus: The ACCORD Trial
by: Jonathan J. Mayl, et al.
Published: (2020-09-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites
by: Keishi Yamasaki, et al.
Published: (2018-07-01)

Experimental and Computational Investigation on the Interaction of Anticancer Drug Gemcitabine with Human Plasma Protein: Effect of Copresence of Ibuprofen on the Binding
by: Mohd Sajid Ali, et al.
Published: (2022-03-01)

Does the lipid profile depend on the comorbidity of overweight/obesity and arterial hypertension in patients with type 2 diabetes mellitus?
by: I.V. Vivsiana, et al.
Published: (2021-08-01)

Effect of Linker’s Length and Sequence on the Structure and Stability of mGLP-1-DARPin Fusion Protein for Treatment of Type 2 Diabetes: A Computational Study
by: Maryam Ehsasatvatan, et al.
Published: (2023-08-01)

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
by: Naomi F. Lange, et al.
Published: (2022-04-01)

LASER DOPPLER FLOWMETRY IN ASSESSMENT OF SPECIFICS OF SKIN MICROHEMOCIRCULATION IN HYPERTENSIVE PATIENTS AND IN ITS COMORBIDITY WITH 2 TYPE DIABETES MELLITUS
by: A. P. Vasiliev, et al.
Published: (2015-12-01)

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease
by: Hirokazu Takahashi, et al.
Published: (2023-04-01)

Structural and Biochemical Features of Human Serum Albumin Essential for Eukaryotic Cell Culture
by: Vibhor Mishra, et al.
Published: (2021-08-01)

Effects of human serun albumin in some biological properties of rhodium(II) complexes
by: Espósito Breno P., et al.
Published: (2000-01-01)

Influence of non-alcoholic steatohepatitis on the renal functional status in patients with type 2 diabetes and diabetic kidney disease
by: Z.Ya. Кotsiubiichuk, et al.
Published: (2023-04-01)

Arterial hypertension prevalence in type 2 diabetes patients (Analysis of Bashkortostan Republic State Diabetes Registry data)
by: E. Kh. Akhmetzyanova, et al.
Published: (2006-02-01)

INTENSITY OF OXIDATIVE STRESS AS A UNIVERSAL MECHANISM OF TISSUE DAMAGE IN NONALCOHOLIC STEATOHEPATITIS AND DIABETIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. QUERCETIN CORRECTION EFFECTIVENESS
by: Oksana S. Khukhlina, et al.
Published: (2021-12-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Decreased Urinary Levels of <i>SIRT1</i> as Non-Invasive Biomarker of Early Renal Damage in Hypertension
by: Olga Martinez-Arroyo, et al.
Published: (2020-09-01)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
by: Stephen D. H. Malnick, et al.
Published: (2022-12-01)

Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach
by: Tanveer A. Wani, et al.
Published: (2018-03-01)